Optimizing treatment strategies for early‐onset mucinous adenocarcinoma of the colon: A <scp>SEER</scp> database analysis
Systemic therapy was associated with a significant survival benefit in patients with stage III early-onset MAC, supporting its role as a cornerstone of treatment despite the histology's presumed chemoresistance.
Authors
- Christopher D. Lopez (ORCID: https://orcid.org/0000-0001-8760-9545)
- Anjelli Wignakumar (ORCID: https://orcid.org/0000-0002-3423-2710)
- Sameh Hany Emile (ORCID: https://orcid.org/0000-0001-7854-5244)
- Cameron G Perrone
- Spencer Barnes (ORCID: https://orcid.org/0000-0003-1103-0953)
- Matthew Bilotti
- S Wexner
Institutions
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
- Mansoura University Hospital (EG)
- Cleveland Clinic Florida (US)
- Florida Atlantic University (US)
Publication Details
- Journal
- Colorectal Disease
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/codi.70390
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00